LexaGene Holdings Inc. (CVE:LXG – Get Free Report) fell 19.2% during mid-day trading on Wednesday . The company traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares were traded during mid-day trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Performance
The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01. The stock has a 50 day simple moving average of C$0.11 and a 200 day simple moving average of C$0.11. The company has a market capitalization of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
See Also
- Five stocks we like better than LexaGene
- Dividend Payout Ratio Calculator
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Insider Trades May Not Tell You What You Think
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How Can Investors Benefit From After-Hours Trading
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
